These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2479337)

  • 41. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Colony-stimulating factors. Therapeutic applications].
    Kusminsky GD; Koziner B
    Sangre (Barc); 1990 Oct; 35(5):381-7. PubMed ID: 2291148
    [No Abstract]   [Full Text] [Related]  

  • 43. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Tamura M; Hattori K; Nomura H; Ono M; Yokota T
    Infect Immun; 1987 Nov; 55(11):2715-20. PubMed ID: 2444540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy.
    Lindemann A; Herrmann F; Oster W; Haffner G; Meyenburg W; Souza LM; Mertelsmann R
    Blood; 1989 Dec; 74(8):2644-51. PubMed ID: 2479425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factor-associated complications and increase in leukocyte number.
    Ferretti G; Papaldo P
    Ann Oncol; 2007 Jun; 18(6):1118-9. PubMed ID: 17586752
    [No Abstract]   [Full Text] [Related]  

  • 46. Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy.
    Schmidberger H; Hess CF; Hoffmann W; Reuss-Borst MA; Bamberg M
    Eur J Cancer; 1993; 29A(14):1927-31. PubMed ID: 7506558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biology and clinical applications of human recombinant granulocyte colony-stimulating factor.
    Gabrilove JL
    Cancer Invest; 1990; 8(2):295-7. PubMed ID: 1698112
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical application of Lishengsu for treatment of leukopenia induced by chemotherapy].
    Jiang NX; Zhang Q; Zhang BH; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):96-8. PubMed ID: 12667300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Granulocyte colony-stimulating factor for gastrointestinal perforation in patients with leukopenia.
    Nishida T; Hasegawa J; Nakao K; Fujita N
    J Trauma; 1996 May; 40(5):727-32. PubMed ID: 8614070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study.
    Dieterle A; Gratwohl A; Ritz R; Obrecht JP; Obrist R
    Ann Oncol; 1991 Jan; 2(1):69-70. PubMed ID: 2009237
    [No Abstract]   [Full Text] [Related]  

  • 51. Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF).
    Motojima H; Kobayashi T; Shimane M; Kamachi S; Fukushima M
    J Immunol Methods; 1989 Mar; 118(2):187-92. PubMed ID: 2466903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamics of recombinant hG-CSF in transgenic goat: preliminary study in the founder during hormonally induced lactation.
    Moura RR; Albuquerque ES; Melo CH; Alcântara-Neto AS; Batista RI; Nunes-Pinheiro DC; Pereira AF; Teixeira DÍ; Melo LM; Serova IA; Andreeva LE; Serov OL; Freitas VJ
    Anim Biotechnol; 2013 Jan; 24(1):10-4. PubMed ID: 23394365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulocyte colony-stimulating factor and neutrophil alkaline phosphatase.
    Ushijima T; Ohbayashi Y; Sato H; Urabe A
    Ann Intern Med; 1989 Jul; 111(1):91. PubMed ID: 2472082
    [No Abstract]   [Full Text] [Related]  

  • 54. Recombinant granulocyte-macrophage colony-stimulating factor in the treatment of HIV-related leucopenia.
    Manfredi R; Cariani T; Latini F; Chiodo F
    Acta Paediatr; 1995 Aug; 84(8):943-4. PubMed ID: 7488824
    [No Abstract]   [Full Text] [Related]  

  • 55. Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor.
    Devereux S; Linch DC; Campos Costa D; Spittle MF; Jelliffe AM
    Lancet; 1987 Dec; 2(8574):1523-4. PubMed ID: 2892078
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparison of 2 strategies in the treatment of radiogenic leukopenia using granulocyte colony stimulating factor].
    Adamietz IA; Rosskopf B; Dapper FD; von Lieven H; Böttcher HD
    Strahlenther Onkol; 1997 Mar; 173(3):170-1. PubMed ID: 9122859
    [No Abstract]   [Full Text] [Related]  

  • 57. High serum colony-stimulating activity of leukocytopenic patients after intravenous infusions of human urinary colony-stimulating factor.
    Motoyoshi K; Takaku F; Miura Y
    Blood; 1983 Sep; 62(3):685-8. PubMed ID: 6349714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I and early phase II studies on human urinary colony stimulating factor.
    Motoyoshi K; Takaku F; Kusumoto K; Miura Y; Yamanaka T; Kimura K
    Jpn J Med; 1982 Jul; 21(3):187-91. PubMed ID: 6982989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trials of colony stimulating factors grow, so do applications, side effects.
    Merz B
    JAMA; 1988 Dec 23-30; 260(24):3555. PubMed ID: 3057248
    [No Abstract]   [Full Text] [Related]  

  • 60. Hematopoietic growth factors as therapeutic agents.
    Donahue RE; Clark SC; Kamen R
    Ann N Y Acad Sci; 1987; 511():10-6. PubMed ID: 3326462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.